Related references
Note: Only part of the references are listed.A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer
Qian Huang et al.
ACTA BIOMATERIALIA (2022)
A network pharmacological approach to reveal the multidrug resistance reversal and associated mechanisms of acetogenins against colorectal cancer
Srijeyagowri Murugaiyaa Pandiyan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Comparison of Colorectal Cancer Stem Cells and Oxaliplatin-Resistant Cells Unveils Functional Similarities
Vanessa Rodriguez-Fanjul et al.
CELLS (2022)
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
M. Michl et al.
VIRCHOWS ARCHIV (2021)
Membranous CD44v6 is upregulated as an early event in colorectal cancer: Downregulation is associated with circulating tumor cells and poor prognosis
Agapi Kataki et al.
ONCOLOGY LETTERS (2021)
Nestin and CD34 expression in colorectal cancer predicts improved overall survival
Athanasios Tampakis et al.
ACTA ONCOLOGICA (2021)
The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy
Zahra Asadzadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Statistical, Clinical, Methodological Evaluation of Local Recurrence Following Transanal Total Mesorectal Excision for Rectal Cancer: A Systematic Review
Hans H. Wasmuth et al.
DISEASES OF THE COLON & RECTUM (2021)
Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery
Martin R. Weiser et al.
JAMA NETWORK OPEN (2021)
The Concept of Cancer Stem Cells in the Context of Classic Carcinogenesis Hypotheses and Experimental Findings
James E. Trosko
LIFE-BASEL (2021)
Translating the Science of Cancer Dormancy to the Clinic
Julio A. Aguirre-Ghiso
CANCER RESEARCH (2021)
Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment
Xia Sun et al.
JOURNAL OF CANCER (2021)
Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway
Xiaotong Sun et al.
CELL BIOCHEMISTRY AND FUNCTION (2020)
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
Zeting Yuan et al.
BRITISH JOURNAL OF CANCER (2020)
Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells
Xingwang Kuai et al.
MEDICAL SCIENCE MONITOR (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
Emerging Roles of Wnt Ligands in Human Colorectal Cancer
Xiaobo Nie et al.
FRONTIERS IN ONCOLOGY (2020)
SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166
Ruben A. Bartolome et al.
ONCOGENE (2020)
ABC transporters Mdr1a/1b, Bcrp1, Mrp2 and Mrp3 determine the sensitivity to PhIP/DSS-induced colon carcinogenesis and inflammation
S. Durmus et al.
ARCHIVES OF TOXICOLOGY (2019)
Cancer cell lipid class homeostasis is altered under nutrient-deprivation but stable under hypoxia
Jan Lisec et al.
BMC CANCER (2019)
Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets
Lorena Vazquez-Iglesias et al.
BIOLOGY OPEN (2019)
LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis
Xuexiu Zhang et al.
BIOLOGICAL CHEMISTRY (2019)
CD44v6 engages in colorectal cancer progression
Lixin Ma et al.
CELL DEATH & DISEASE (2019)
Concise update on colorectal cancer epidemiology
Camilla Mattiuzzi et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer
Zhengwei Leng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity
Yongqiang Hua et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
Felipe de Sousa e Melo et al.
NATURE (2017)
Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis
Koichi Suzuki et al.
ONCOLOGY LETTERS (2017)
The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer
S. M. Riajul Wahab et al.
CLINICAL COLORECTAL CANCER (2017)
Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State
Masoud H. Manjili
CANCER RESEARCH (2017)
EpCAM as multi-tumour target for near-infrared fluorescence guided surgery
P. B. A. A. van Driel et al.
BMC CANCER (2016)
Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors
Emanuela Guerra et al.
CLINICAL CANCER RESEARCH (2016)
Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma
Chungang Liu et al.
HEPATOLOGY (2016)
Acquisition of anticancer drug resistance is partially associated with cancer sternness in human colon cancer cells
Flaria El Khoury et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
Lin Lv et al.
TUMOR BIOLOGY (2016)
ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells
Lijun Ma et al.
TUMOR BIOLOGY (2016)
Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells
Bo Young Oh et al.
ONCOTARGET (2016)
An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer
Mei-Ying Liao et al.
ONCOTARGET (2015)
ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9
Alvaro Gilsanz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
AC133 expression associated with poor prognosis in stage II colorectal cancer
Xiaofang Ying et al.
MEDICAL ONCOLOGY (2013)
Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
Chunxia Wang et al.
ONCOLOGY REPORTS (2012)
Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines
Zhen Liu et al.
Chinese Journal of Cancer (2012)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer
Yan-Lei Ma et al.
MEDICAL ONCOLOGY (2010)
Role of oxaliplatin in the treatment of colorectal cancer
Pasquale Comella
Therapeutics and Clinical Risk Management (2010)
Trop2: A possible therapeutic target for late stage epithelial carcinomas
Rafael Cubas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
David Horst et al.
CANCER INVESTIGATION (2009)
Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver
Mayuko Okabe et al.
DEVELOPMENT (2009)
Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer
Y. J. Fang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin
LCLT van Kempen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group
MJ Piccart et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
